ALCYONE Paves Way For J&J/Genmab's Darzalex In Frontline Myeloma

Data supporting a role for J&J/Genmab's anti-CD38 monoclonal antibody in newly diagnosed multiple myeloma are "as good as could be expected," but the backbone regimen in the trial is rarely used in the US.